Clinical Trials and Studies

Lung and Chest Tumors

• A Study of Ifinatamab Deruxtecan versus Treatment of Physician's Choice in Subjects with Relapsed Small Cell Lung Cancer (IDeate-Lung02)
• A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
• ALCHEMIST Chemo-IO Study: Treatment for Treatment for Non-Small Cell Lung Cancer
• An ALCHEMIST Treatment Trial: Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer
• Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
• Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
• Prolonged Air Leak (PAL) Autologous Blood Patch Intervention Trial
• Pulmonary and Critical Care Registry
• S1900G : Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
• Study of First Line Treatment and Maintenance in Non-Small Cell Lung Cancer
• TETON Study: Inhalation Treatment for IPF